SEC Form 4 · accession 0001657070-18-000003
KEWAUNEE SCIENTIFIC CORP /DE/ · KEQU
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Dana L Dahlgren
Officer — VP-Sales & Marketing-Americas
Period of report
Mar 20, 2018
Accepted (ET)
Mar 21, 2018 · 11:14 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000055529
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Mar 20, 2018 | M | 1,500 | $12.66 | A | 7,312 | D | |
| Common StockF1 | Mar 20, 2018 | M | 2,000 | $10.64 | A | 9,312 | D | |
| Common StockF1 | Mar 20, 2018 | M | 1,500 | $8.59 | A | 10,812 | D | |
| Common StockF1 | Mar 20, 2018 | M | 3,000 | $11.78 | A | 13,812 | D | |
| Common StockF1 | Mar 20, 2018 | M | 3,000 | $15.85 | A | 16,812 | D | |
| Common Stock | Mar 20, 2018 | F | 4,291 | $31.70 | D | 12,521 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to BuyF2 | $12.66 | Mar 20, 2018 | M | 1,500 | D | Aug 26, 2013 | Aug 26, 2019 | Common Stock | 1,500 | 0 | D |
| Option to BuyF2 | $10.64 | Mar 20, 2018 | M | 2,000 | D | Aug 25, 2014 | Aug 25, 2020 | Common Stock | 2,000 | 0 | D |
| Option to BuyF2 | $8.59 | Mar 20, 2018 | M | 1,500 | D | Aug 24, 2015 | Aug 24, 2021 | Common Stock | 1,500 | 0 | D |
| Option to BuyF2 | $11.78 | Mar 20, 2018 | M | 3,000 | D | Aug 22, 2016 | Aug 22, 2022 | Common Stock | 3,000 | 0 | D |
| Option to BuyF2 | $15.85 | Mar 20, 2018 | M | 3,000 | D | Aug 28, 2017 | Aug 28, 2023 | Common Stock | 3,000 | 0 | D |
Explanation of responses
- F1Consideration for the exercise of the underlying option to buy was paid through a "net exercise" by directing the company to retain as payment for the total exercise cost a sufficient number of shares of Common Stock that would have been otherwise received upon this exercise as reported below on this Form 4 report.
- F2Employee stock option granted under Employee Stock Option Plan under Rule 16b-3.